Indica Labs: Learn How HALO Macrodissection Solutions Quantifies Tumor Content and Guides ROI Selection
recent articles
Indica Labs: HALO Macrodissection Solutions harness the power of AI to quantify and visualize tumor content to improve the reliability of downstream molecular testing in lung, colorectal, breast, and prostate cancers. Accurate estimation of...
VISTA, California — March 19, 2026 — Leica Biosystems, a Danaher company and a global leader in digital and anatomic pathology solutions, announces major expansion of the Aperio AI Store, reinforcing its momentum as a rapidly growing...
Melbourne, Australia — (March 17, 2026) — Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, and Bio-Techne (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products,...
The Aiforia Prostate Cancer Biopsy AI application is designed to enhance pathologists’ diagnostic workflow by providing world-class tools for comprehensive analysis and reporting of prostate needle biopsies. Aiforia Technologies Plc, Press...
Leica Biosystems: Transformational automation accelerates time to results by up to 93.6% for cytogenetics laboratories worldwide VISTA, California – March 13, 2026 – Leica Biosystems, a Danaher company and a global leader in digital and...
Indica Labs: Learn how unbiased high-dimensional analysis can be seamlessly combined with AI-powered HALO workflows for multiplex images! Masterclass: Unlock Cell Population Discovery Using HALO® High Dimensional...































